Educational Activity

Page 3

Posts about this type

JCP
Educational Activity

December 17, 2019

Two medications are FDA-approved to treat tardive dyskinesia, and new long-term evidence has been reported. Follow along as expert Joseph P. McEvoy, MD, reviews the evidence.
Joseph P. McEvoy
JCP
Educational Activity

December 10, 2019

Do you proactively assess patients for tardive dyskinesia? Here, learn about screening and diagnosis from an expert.
Daniel E. Kremens
JCP
Educational Activity

December 3, 2019

How does tardive dyskinesia affect patients' work and relationships? Should TD be treated even if patients lack insight into its presence? Dr Joseph McEvoy considers these questions and more...
Joseph P. McEvoy
JCP
Educational Activity

September 24, 2019

In a series of brief video segments, experts in neurology, psychiatry, and primary care discuss the diagnosis and treatment of Alzheimer's disease.
Alireza Atri, Simon Sheard, Danielle Goldfarb
JCP
Educational Activity

July 30, 2019

New mechanisms of action present new opportunities to improve outcomes for patients with depression. Listen to a panel of experts discuss best practices and novel antidepressants at the 2019...
Leslie Citrome, Bradley N. Gaynes, Joseph F. Goldberg, et al
JCP
Educational Activity

June 25, 2019

Meaningful benefits can be derived from the evaluation of cognition in older adults when there is possible cognitive impairment and dementia. Here, experts explain how brief cognitive assessment tools...
Lynn Shaughnessy, Simon Sheard, Danielle Goldfarb, et al
JCP
Educational Activity

March 26, 2019

Relapse of schizophrenia often occurs due to treatment nonadherence. Long-acting injectable (LAI) antipsychotics can improve adherence but are underused. Watch this Webcast to hear interviews with patients and learn...
John Lauriello, Diana O. Perkins
JCP
Educational Activity

March 19, 2019

Disclosing a diagnosis of dementia can be one of the most challenging aspects of care for clinicians. However difficult the diagnosis is to give, disclosing the diagnosis in a...
Danielle Goldfarb, Simon Sheard, Lynn Shaughnessy, et al
JCP
Educational Activity

February 20, 2019

Children whose bipolar disorder is inadequately treated often grow into adults who are unable to manage their illness. Read this new Brief Report to discover the most effective treatment...
Melissa P. DelBello
JCP
Educational Activity

February 20, 2019

Despite the availability of effective treatments for MDD, many individuals have difficulty achieving remission. Residual symptoms can be difficult to differentiate from treatment side effects. Through 2 comic-based case...
Roger S. McIntyre
JCP
Educational Activity

February 20, 2019

Most people who experience a depressive episode are greatly impaired by it. No one-size-fits-all therapy is available, and most patients require multiple treatment steps. Check out this CME activity...
Michael E. Thase
JCP
Educational Activity

February 20, 2019

At least half of the cases of bipolar disorder begin in childhood or adolescence. How do you decide whether a young patient's symptoms indicate bipolar disorder? Read this CME...
Manpreet K. Singh
JCP
Educational Activity

June 26, 2018

Although levodopa is effective for treating Parkinson disease, physicians and patients face significant management challenges related to disease progression. Patients may develop fluctuations in motor symptoms and dyskinesias as...
Adolfo Ramirez-Zamora
JCP
Educational Activity

April 25, 2018

How do you select among treatments for bipolar disorder in adolescents? Check out this brief report activity to explore the efficacy and safety of lithium, anticonvulsants, and atypical antipsychotics...
Robert L. Findling
JCP
Educational Activity

April 19, 2018

As many as 2 million youths in the US alone could have bipolar disorder. In this CME brief report, get up-to-date on common presentations of pediatric bipolar disorder, DSM-5...
Kiki D. Chang
JCP
Educational Activity

February 21, 2018

Do you know which of your patients are at risk for developing tardive dyskinesia? Watch this Webcast to learn about how to prevent tardive dyskinesia in your patients and...
J. Sloan Manning, Joseph P. McEvoy
JCP
Educational Activity

February 21, 2018

Tune in to this podcast as experts discuss 2 patient cases—one involving co-occurring insomnia and depression and another comprising PTSD, substance abuse, insomnia, and nightmares. Drs Benca and Buysse...
Ruth M. Benca, Daniel J. Buysse
JCP
Educational Activity

February 21, 2018

Listen to this podcast as experts discuss 2 patient cases focusing on diagnosing and treating co-occurring insomnia and mental illness. The first case features a 32-year-old man with bipolar...
Ruth M. Benca, Daniel J. Buysse
JCP
Educational Activity

February 21, 2018

Larry Culpepper, Raymond W. Lam, Roger S. McIntyre
JCP
Educational Activity

February 21, 2018

Your patients taking antipsychotics may be at risk for developing tardive dyskinesia. In this Case and Comment activity, follow Martha, a 60-year-old woman being treated with an antipsychotic medication...
J. Sloan Manning
JCP
Educational Activity

February 21, 2018

Do you know how to manage tardive dyskinesia symptoms? In this Case and Comment activity, consider the case of John, a 25-year-old project manager diagnosed with bipolar disorder who...
Joseph P. McEvoy
JCP
Educational Activity

February 21, 2018

Roger S. McIntyre
JCP
Educational Activity

February 21, 2018

Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for patients with serious mental illness but are underused. Watch this Webcast to learn how to identify...
Christoph U. Correll, John Lauriello
JCP
Educational Activity

January 25, 2018

A series of 6 brief educational videos featuring expert insight and comments by actual patients and their family members helps people understand the risk factors for TD, recognize the...
Joseph P. McEvoy, Andrew A. Nierenberg

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe